-+ 0.00%
-+ 0.00%
-+ 0.00%

Vir Biotechnology names Aziz Sawaf as CFO effective Oct. 5, 2026

PUBT·10/01/2026 12:31:06
Listen to the news
Vir Biotechnology names Aziz Sawaf as CFO effective Oct. 5, 2026
  • Vir Biotechnology appointed Aziz Sawaf as executive vice president and chief financial officer, effective Oct. 5, 2026.
  • Sawaf will oversee finance, IT, investor relations.
  • He joins from Theravance Biopharma, where he has served as CFO since 2023 and SVP of operations strategy since 2025.
  • Earlier roles included finance leadership positions at Theravance, preceded by R&D and commercial finance work at Gilead Sciences.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610010830BIZWIRE_USPR_____20261001_BW025380) on October 01, 2026, and is solely responsible for the information contained therein.